Medicine and Dentistry
Breast Cancer
100%
Lymph Node
100%
Adjuvant Therapy
100%
Tamoxifen
100%
Estrogen Receptor
81%
Disease Free Survival
45%
Overall Survival
45%
Neoplasm
36%
Adjuvant Chemotherapy
27%
Malignant Neoplasm
18%
Diseases
18%
Fluorouracil
9%
Cyclophosphamide
9%
Methotrexate
9%
CMF (Chemotherapy)
9%
Nursing and Health Professions
Breast Cancer
100%
Adjuvant Therapy
100%
Tamoxifen
100%
Estrogen Receptor
81%
Confidence Interval
72%
Overall Survival
45%
Disease Free Survival
45%
Neoplasm
36%
Adjuvant Chemotherapy
27%
Malignant Neoplasm
18%
Diseases
18%
Methotrexate
9%
Fluorouracil
9%
Cyclophosphamide
9%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Tamoxifen
100%
Estrogen Receptor
81%
Overall Survival
45%
Disease Free Survival
45%
Chemotherapy
45%
Neoplasm
36%
Malignant Neoplasm
18%
Diseases
18%
Methotrexate
9%
Cyclophosphamide
9%
Fluorouracil
9%
Agricultural and Biological Sciences
Lymph Node
100%
Tamoxifen
100%
Estrogen Receptor
81%
Confidence Interval
72%
Immunology and Microbiology
Disease Free Survival
100%
Overall Survival
100%
Lymph Node
100%
Methotrexate
20%
Cyclophosphamide
20%